Journal of Cancer Therapy
Vol.6 No.11(2015), Paper ID 60285, 8
pages
DOI:10.4236/jct.2015.611104
Role of Urokinase-Type Plasminogen Activator Receptors as an Early Detector for Treatment Outcome in Adult Acute Myeloid Leukemia in Egyptian Patients
Hanan R. Nassar, Eman Z. Kandeel, Laila A. E. Hegazy, Amany M. Helal, Tarek Darwish, Soad A. Eltokhy
Medical Oncology, NCI, Cairo, Egypt
Clinical Pathology, NCI, Cairo, Egypt
Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt
Medical Oncology, NCI, Cairo, Egypt
Medical Oncology, NCI, Cairo, Egypt
Clinical Pathology, NCI, Cairo, Egypt
Copyright © 2015 Hanan R. Nassar, Eman Z. Kandeel, Laila A. E. Hegazy, Amany M. Helal, Tarek Darwish, Soad A. Eltokhy et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Nassar, H. , Kandeel, E. , Hegazy, L. , Helal, A. , Darwish, T. and Eltokhy, S. (2015) Role of Urokinase-Type Plasminogen Activator Receptors as an Early Detector for Treatment Outcome in Adult Acute Myeloid Leukemia in Egyptian Patients.
Journal of Cancer Therapy,
6, 963-970. doi:
10.4236/jct.2015.611104.